These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12670536)

  • 1. Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase.
    Hausch F; Halttunen T; Mäki M; Khosla C
    Chem Biol; 2003 Mar; 10(3):225-31. PubMed ID: 12670536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular warhead and its target: tissue transglutaminase and Celiac Sprue.
    Schuppan D; Dieterich W
    Chem Biol; 2003 Mar; 10(3):199-201. PubMed ID: 12670530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides.
    Lexhaller B; Ludwig C; Scherf KA
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors.
    Song M; Hwang H; Im CY; Kim SY
    J Med Chem; 2017 Jan; 60(2):554-567. PubMed ID: 28122456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of potent water-soluble tissue transglutaminase inhibitors.
    Griffin M; Mongeot A; Collighan R; Saint RE; Jones RA; Coutts IG; Rathbone DL
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5559-62. PubMed ID: 18812257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles.
    Watts RE; Siegel M; Khosla C
    J Med Chem; 2006 Dec; 49(25):7493-501. PubMed ID: 17149878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
    Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
    J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of transglutaminase 2 in celiac disease pathogenesis.
    Klöck C; Diraimondo TR; Khosla C
    Semin Immunopathol; 2012 Jul; 34(4):513-22. PubMed ID: 22437759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
    Lexhaller B; Ludwig C; Scherf KA
    Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2.
    Dafik L; Khosla C
    Chem Biol; 2011 Jan; 18(1):58-66. PubMed ID: 21276939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.
    Choi K; Siegel M; Piper JL; Yuan L; Cho E; Strnad P; Omary B; Rich KM; Khosla C
    Chem Biol; 2005 Apr; 12(4):469-75. PubMed ID: 15850984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten.
    Feriotto G; Calza R; Bergamini CM; Griffin M; Wang Z; Beninati S; Ferretti V; Marzola E; Guerrini R; Pagnoni A; Cavazzini A; Casciano F; Mischiati C
    Amino Acids; 2017 Mar; 49(3):551-565. PubMed ID: 27699491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.
    Siegel M; Xia J; Khosla C
    Bioorg Med Chem; 2007 Sep; 15(18):6253-61. PubMed ID: 17590341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.
    Klöck C; Jin X; Choi K; Khosla C; Madrid PB; Spencer A; Raimundo BC; Boardman P; Lanza G; Griffin JH
    Bioorg Med Chem Lett; 2011 May; 21(9):2692-6. PubMed ID: 21215619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unprecedented dual antagonist and agonist of human Transglutaminase 2.
    Yi MC; Palanski BA; Quintero SA; Plugis NM; Khosla C
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4922-4926. PubMed ID: 26004580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction profiling of a set of acrylamide-based human tissue transglutaminase inhibitors.
    Jasim MH; Rathbone DL
    J Mol Graph Model; 2018 Jan; 79():157-165. PubMed ID: 29179065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase as a therapeutic target for celiac disease.
    Sulic AM; Kurppa K; Rauhavirta T; Kaukinen K; Lindfors K
    Expert Opin Ther Targets; 2015 Mar; 19(3):335-48. PubMed ID: 25410283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and inhibition of transglutaminase 2 in mice.
    Dafik L; Albertelli M; Stamnaes J; Sollid LM; Khosla C
    PLoS One; 2012; 7(2):e30642. PubMed ID: 22319575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase 2 undergoes a large conformational change upon activation.
    Pinkas DM; Strop P; Brunger AT; Khosla C
    PLoS Biol; 2007 Dec; 5(12):e327. PubMed ID: 18092889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Wilhelmus MMM; Drukarch B; van Dam AM
    PLoS One; 2018; 13(4):e0196433. PubMed ID: 29689097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.